The National Center for Advancing Translational Sciences is doling out $12.7 million in new grants to nine academic research teams that will try to come up with new uses for existing compounds that are owned by major pharmaceutical firms.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

An NCATS License

Making the Most

Hoping for More

Mining Data Mountains

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.